Navigation Links
The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts
Date:5/7/2009

e stockholders, without compensating them.

Your Board is singularly qualified, with diverse senior level business and industry experience and in-depth knowledge of The Quigley Corporation. The incumbent Board, together with your senior management team, has the industry and operational experience to manage this unique company, which combines a leading OTC product marketer with a pharmaceutical R&D subsidiary.

We believe that in his attempt to gain control of your Company, Karkus is effectively asking you to start over again with a new and unqualified Board. We've come too far and achieved many key milestones, and with your continued support, we will stay on course and further implement our strategic plans to enhance stockholder value.

PROTECT YOUR INVESTMENT - VOTE THE WHITE PROXY TODAY

Your vote at this year's Annual Meeting is more important than it has ever been. As a result, we are urging all our fellow stockholders to vote the WHITE proxy card today and to discard any materials that you may receive from Karkus. Please do not return any blue cards, even as a protest vote, as only your latest dated card will be counted at the Annual Meeting. Acting together, we are confident that we can ward off Karkus' attempt to take over the Company and your Board will be able to get back to the business of enhancing stockholder value.

If you have any questions or need assistance in voting the WHITE proxy card, please call our proxy solicitors, MacKenzie Partners, Inc. toll-free at (800) 322-2885 or (212) 929-5500 or by email at Quigley@mackenziepartners.com. You may also be able to vote by telephone or internet and we encourage you to do so by following the instructions on th
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. The Quigley Corporation Reports First Quarter 2009 Results
2. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
3. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
4. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
5. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
6. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
7. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
8. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
9. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
10. Service Corporation International Announces First Quarter 2009 Financial Results
11. Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... soccer tickets. The first week in September will be ... Teams from Brazil, Colombia, Mexico, Chile, Ecuador and Bolivia ... The following matches will take place between September 5th - ... Stadium on Tuesday, September 9th , Mexico vs. ...
(Date:9/2/2014)... NY (PRWEB) September 02, 2014 The ... VisitandCare.com , was designed to help doctors manage foreign ... to boost patient conversion rates and clink revenue. Since ... 60 percent increase in sales revenue and a 70 ... CRM software in their own healthcare practices. , With ...
(Date:9/2/2014)... you are hospitalized, but your outpatient doctor does ... office for follow-up care, but your doctor does ... stay? Missing or incomplete communication from hospitals ... to poor experiences and lead to hospital readmissions. ... implementing guidelines can improve hospitals, communication during patient ...
(Date:9/2/2014)... Experimental Biology and Medicine that appears ... and medicine of microphysiological systems" and describes the ... Program directed by the National Center for Advancing ... Health (NIH) and funded in part by the ... Agency (DARPA) and the Food and Drug Administration ...
(Date:9/2/2014)... Ohio (PRWEB) September 02, 2014 For ... managed IT security and network services company, has been ... nation. Inc. magazine's Inc. 5000 list highlights America's fastest ... each year since the list inception in 2007. , ... has grown 144 percent over the past three years. ...
Breaking Medicine News(10 mins):Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Can data motivate hospital leaders to improve care transitions? 2Health News:Microphysiological systems will revolutionize experimental biology and medicine 2Health News:Microphysiological systems will revolutionize experimental biology and medicine 3Health News:CentraComm Named to Inc. 5000 for 8th Consecutive Year 2
... battle super bugs, including MRSA, has found its way to ... as Tygacil, is one of the few new antibiotics to ... ,Micro organisms have undergone mutations that enabled them ... infections, such as MRSA, in hospitals. ,The new ...
... new study suggests that male circumcision could significantly reduce ... findings that has been published in the Journal PLoS ... that suggested circumcision reduced HIV infection risk in heterosexual ... researchers have used that data and conducted the research, ...
... study in the July issue of Archives of General Psychiatry, ... fact more prone to depression. //The study on more than ... percent increased risk of developing mood and anxiety disorders including, ... is an important public health issue because both of these ...
... agreed to reconduct lab tests to find out whether a ... as early as 2003, after eight of its scientists alleged ... Ministry of Health said it was conducting new lab tests ... ,"In accordance with World Health Organisation and China's diagnostic standards ...
... compares two common inhalers for patients suffering from ... reduces respiratory-related hospitalizations and respiratory deaths, but the ... of cases -- increases respiratory deaths. ... 22 trials with 15,276 participants found that common ...
... Researchers at the Institute Of Cancer Research have discovered a ... the disease.// ,It is found that if a ... being diagnosed with breast cancer doubles. This would serve as ... risk of cancer and thereby help treat and prevent the ...
Cached Medicine News:Health News:New Drugs To Combat Mutant Bugs 2Health News:Practise Of Male Circumcision In Africa May Reduce HIV Risks 2Health News:COPD Patients Using Beta-agonist Inhalers Are at Risk 2
(Date:9/2/2014)... commands the vital signs monitoring devices market with ... . The North American and European vital signs ... $907.0 million, respectively, by the end of 2013. They ... rising number of elderly people across these economies. The ... demand owing to the rising demand for home health ...
(Date:9/2/2014)... Reportlinker.com announces that a new market ... Acute Heart Failure Global Clinical Trials Review, ... Acute Heart Failure Global Clinical Trials ... clinical trial report, "Acute Heart Failure Global Clinical ... Acute Heart Failure clinical trial scenario. This report ...
(Date:9/2/2014)... 2014   Santa Clara dentist , Dr. ... for Invisalign. Invisalign is an orthodontic system that uses ... often the orthodontic treatment of choice for older teens ... it. For a limited time, patients can try Invisalign ... the usual cost. This offer cannot be combined, and ...
Breaking Medicine Technology:Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... 2007 - CELSION CORPORATION,(AMEX:CLN) today announced the ... using ThermoDox(R), to treat non-resectable liver,cancer. The ... Research,and Development Agreement (CRADA) was performed at ... Institutes of Health, under,the leadership of Dr. ...
... NEW YORK--(BUSINESS WIRE)--May 30, 2007 - INNOVIVE ... data from a Phase I,trial of INNO-406, ... for Gleevec(R)-resistant or,treatment-intolerant chronic myelogenous leukemia, will ... Clinical Oncology Annual,Meeting. The meeting takes place ...
Cached Medicine Technology:Celsion Completes Enrollment in Phase I Liver Cancer Study 2Celsion Completes Enrollment in Phase I Liver Cancer Study 3Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
The Triage® Parasite Panel is an enzyme immunoassay used for the detection of antigens specific for Giardia lamblia, Entamoeba histolytica/dispar and Cryptosporidium parvum in fresh or freshly fr...
... Urostym™ provides the most current ... including urinary and fecal incontinence. ... easily providing complete patient information ... Customer testimonials have proven Urostym™ ...
... affordable path to Sonesta flexibility. Three ... back adjustments. Packaged with basic accessories, ... of Sonesta add-ons, allowing you to ... needs; complete Sonesta flexibility at an ...
The Triage Drugs of Abuse Panel is the leading rapid drug screen used by U.S. hospitals. The Triage Drugs of Abuse Panel is a small, handheld urine test that provides qualitative results for up to n...
Medicine Products: